Manufacturing

Insilico and Bora Form $2.5 Billion AI Drug Alliance
Research & Development Insilico and Bora Form $2.5 Billion AI Drug Alliance

The fusion of generative artificial intelligence with traditional pharmaceutical manufacturing has reached a critical tipping point where computational blueprints now dictate the speed of global medical delivery. The current biopharmaceutical industry has moved beyond isolated computational

Is Purification the New Bottleneck in AI Drug Discovery?
Tech & Innovation Is Purification the New Bottleneck in AI Drug Discovery?

Silicon intelligence has officially outpaced carbon-based physical labor in the laboratory, creating a strange reality where computers can dream up life-saving molecules in seconds while the humans tasked with isolating those substances are stuck scraping glass vials and waiting for solvents to

Frances Arnold Uses Directed Evolution to Engineer Enzymes
Management & Regulatory Frances Arnold Uses Directed Evolution to Engineer Enzymes

The traditional boundaries between biological systems and mechanical engineering have blurred as researchers move beyond the static limitations of rational design to embrace the chaotic yet efficient power of natural selection. For decades, the ambition of protein engineering was restricted by the

Can AI Bridge the Gap to Industrial Biomanufacturing?
Biotech & Bioprocessing Can AI Bridge the Gap to Industrial Biomanufacturing?

The global manufacturing landscape is currently undergoing a radical transformation as industries seek to replace traditional petroleum-dependent processes with sustainable, bio-based alternatives that utilize engineered microorganisms. This paradigm shift, often referred to as biomanufacturing,

Sustainability Redefines Success in APAC Biomanufacturing
Management & Regulatory Sustainability Redefines Success in APAC Biomanufacturing

The rapid evolution of global biologics supply chains has forced a fundamental recalculation of what constitutes a premium partnership in the Asia-Pacific manufacturing landscape. For decades, the region secured its dominance by offering unparalleled speed and cost-efficiency, but as the industry

Can the FDA PreCheck Pilot Boost Domestic Drug Manufacturing?
Management & Regulatory Can the FDA PreCheck Pilot Boost Domestic Drug Manufacturing?

The persistent fragility of the American pharmaceutical supply chain has reached a critical juncture where relying solely on reactive measures is no longer a viable strategy for national health security. To address this, the Food and Drug Administration has introduced the PreCheck Pilot Program, a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later